Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan vs Lansoprazole in Erosive Esophagitis
NCT02388724Phase 3Completed
- Sponsor
- Takeda
- Start
- Mar 2015
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial of vonoprazan in erosive esophagitis (EE) (2 arms), sponsored by Takeda. Primary endpoint: Percentage of Participants With Endoscopic Healing of Erosive Esophagitis at 8 weeks. Started Mar 2015; status: completed.
02
Drugs
vonoprazan
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on NCT02388724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02388724.